# sources

title: npr.org: Glp 1 drugs like ozempic can curb addiction risk study finds
node_name: GLP-1 Gut-Brain Dopamine Reward Circuit
created_at: 2026-04-19 13:39:02
url:
https://www.npr.org/2026/03/05/nx-s1-5732492/glp-1-drugs-like-ozempic-can-curb-addiction-risk-study-finds


node_name: GLP-1 Insurance Premium Paradox
created_at: 2026-04-19 13:39:02
url:
https://www.ebri.org/content/full/glp-1-coverage-and-its-impact-on-employment-based-health-plan-premiums--a-simulation-based-analysis

title:
ebri.org: Glp 1 coverage and its impact on employment based health plan premiums a simulation based analysis


title: bakeryandsnacks.com: Snack industry faces 2025 reset amid glp 1 inflation
node_name: GLP-1 Food Industry Demand Shock
created_at: 2026-04-19 13:39:02
url:
https://www.bakeryandsnacks.com/Article/2025/05/12/snack-industry-faces-2025-reset-amid-glp-1-inflation/


title: jilc.syr.edu: Lighter carts and shrinking profits the impact of glp 1s on the western food industry
node_name: GLP-1 Food Industry Demand Shock
created_at: 2026-04-19 13:39:02
url:
https://jilc.syr.edu/2026/04/08/lighter-carts-and-shrinking-profits-the-impact-of-glp-1s-on-the-western-food-industry/


title: equilibriumecon.wisc.edu: A heavy price the economic and social costs of glp 1 weight loss drugs
node_name: GLP-1 Perpetual Dependency Revenue Model
created_at: 2026-04-19 13:39:02
url:
https://equilibriumecon.wisc.edu/2025/01/09/a-heavy-price-the-economic-and-social-costs-of-glp-1-weight-loss-drugs/


title: ama-assn.org: Spending glp 1s has grown dramatically here are details
node_name: Novo Nordisk
created_at: 2026-04-19 13:39:02
url:
https://www.ama-assn.org/public-health/behavioral-health/spending-glp-1s-has-grown-dramatically-here-are-details


title: themedicinemaker.com: Oral glp 1s won t win on convenience they ll win on cmc
node_name: GLP-1 Peptide Manufacturing Bottleneck
created_at: 2026-04-19 13:39:02
url:
https://themedicinemaker.com/issues/2026/articles/january/oral-glp-1s-won-t-win-on-convenience-they-ll-win-on-cmc/


title: bioxconomy.com: Glp 1s forced industry s hand on sustainable peptide synthesis says expert
node_name: GLP-1 Peptide Manufacturing Bottleneck
created_at: 2026-04-19 13:39:02
url:
https://www.bioxconomy.com/modalities/glp-1s-forced-industry-s-hand-on-sustainable-peptide-synthesis-says-expert


title: investor.lilly.com: Fda approves lillys foundayotm orforglipron only glp 1 pill
node_name: Orforglipron Small Molecule GLP-1 Revolution
created_at: 2026-04-19 13:39:02
url:
https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill


title: news.northwestern.edu: Why do 50 75 of people stop taking glp 1 drugs within a year
node_name: GLP-1 Adherence Cliff
created_at: 2026-04-19 13:39:02
url:
https://news.northwestern.edu/stories/2024/11/why-do-50-75-of-people-stop-taking-glp-1-drugs-within-a-year


title: beveragedaily.com: Alcohol decline drivers affordability glp 1 drugs health
node_name: GLP-1 Dopamine Demand Destruction
created_at: 2026-04-19 13:39:02
url:
https://www.beveragedaily.com/Article/2026/02/13/alcohol-decline-drivers-affordability-glp-1-drugs-health/


title: itif.org: A shot at a healthier future the transformative potential of glp 1s
node_name: GLP-1 Labor Productivity GDP Channel
created_at: 2026-04-19 13:39:02
url:
https://itif.org/publications/2025/08/18/a-shot-at-a-healthier-future-the-transformative-potential-of-glp-1s/


title: shrm.org: Glp 1 drugs reduce health costs employers over long term
node_name: GLP-1 Labor Productivity GDP Channel
created_at: 2026-04-19 13:39:02
url:
https://www.shrm.org/topics-tools/news/benefits-compensation/glp-1-drugs-reduce-health-costs-employers-over-long-term


title: diabetes.org: New glp 1 therapies enhance quality weight loss improving muscle 0
node_name: GLP-1 Lean Mass Loss Sarcopenia Problem
created_at: 2026-04-19 13:39:02
url:
https://diabetes.org/newsroom/press-releases/new-glp-1-therapies-enhance-quality-weight-loss-improving-muscle-0


node_name: GLP-1 Lean Mass Loss Sarcopenia Problem
created_at: 2026-04-19 13:39:02
url:
https://www.pharmacytimes.com/view/bimagrumab-semaglutide-combination-achieves-significant-weight-loss-while-preserving-muscle-mass

title:
pharmacytimes.com: Bimagrumab semaglutide combination achieves significant weight loss while preserving muscle mass


title: talkingmedicines.com: Glp 1s in india a new frontier in affordable weight loss and diabetes care
node_name: GLP-1 Medicare Price Collapse Mechanism
created_at: 2026-04-19 13:39:02
url:
https://talkingmedicines.com/2026/03/glp-1s-in-india-a-new-frontier-in-affordable-weight-loss-and-diabetes-care/


title: investor.lilly.com: Lillys triple agonist retatrutide delivered weight loss average
node_name: Retatrutide Triple Agonist Efficacy Escalation
created_at: 2026-04-19 13:39:02
url:
https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-weight-loss-average


node_name: Retatrutide Triple Agonist Efficacy Escalation
created_at: 2026-04-19 13:39:02
url:
https://www.biospace.com/drug-development/lillys-retatrutide-scores-triple-trial-triumph-with-26-weight-loss-but-new-safety-signal-emerges

title:
biospace.com: Lillys retatrutide scores triple trial triumph with 26 weight loss but new safety signal emerges


node_name: Retatrutide Triple Agonist Efficacy Escalation
created_at: 2026-04-19 13:39:02
url:
https://www.fiercebiotech.com/biotech/novo-nordisk-expands-pivotal-amycretin-program-after-dual-agonist-shines-diabetes

title:
fiercebiotech.com: Novo nordisk expands pivotal amycretin program after dual agonist shines diabetes


title: munichre.com: Glp 1 therapies and mortality risk implications for life insurers
node_name: GLP-1 Life Insurance Actuarial Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.munichre.com/us-life/en/insights/clinical-knowledge/glp-1-therapies-and-mortality-risk-implications-for-life-insurers.html


node_name: GLP-1 Life Insurance Actuarial Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.insurancebusinessmag.com/reinsurance/news/breaking-news/life-insurers-face-new-risk-puzzle-and-why-weightloss-drug-benefits-may-not-last-565275.aspx

title:
insurancebusinessmag.com: Life insurers face new risk puzzle and why weightloss drug benefits may not last 565275


node_name: GLP-1 Multi-Indication TAM Cascade
created_at: 2026-04-19 13:39:02
url:
https://www.prnewswire.com/news-releases/fda-approves-ozempic-semaglutide-as-the-only-glp-1-ra-to-reduce-the-risk-of-worsening-kidney-disease-and-cardiovascular-death-in-adults-with-type-2-diabetes-and-chronic-kidney-disease-302362466.html

title:
prnewswire.com: Fda approves ozempic semaglutide as the only glp 1 ra to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease 302362466


title: foodprocessing.com: 2026 the food industrys great reformulation
node_name: CPG Great Reformulation Response
created_at: 2026-04-19 13:39:02
url:
https://www.foodprocessing.com/ingredients/article/55342584/2026-the-food-industrys-great-reformulation


node_name: CPG Great Reformulation Response
created_at: 2026-04-19 13:39:02
url:
https://www.foodnavigator.com/Article/2026/02/26/big-foods-race-to-reinvent-kraft-heinz-nestle-unilever-ferrero-mars-pepsico-hershey/

title:
foodnavigator.com: Big foods race to reinvent kraft heinz nestle unilever ferrero mars pepsico hershey


title: healio.com: Qa glp1 drugs may benefit ckd transplant patients with type 2 diabetes
node_name: GLP-1 Dialysis Industry Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.healio.com/news/nephrology/20250915/qa-glp1-drugs-may-benefit-ckd-transplant-patients-with-type-2-diabetes


title: mercer.com: Glp 1 considerations for 2026 your questions answered
node_name: GLP-1 Digital Health Adherence Economy
created_at: 2026-04-19 13:39:02
url:
https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/


title: morganlewis.com: Glp 1 coverage obesity and the ada what employer health plan sponsors need to know
node_name: GLP-1 Digital Health Adherence Economy
created_at: 2026-04-19 13:39:02
url:
https://www.morganlewis.com/blogs/mlbenebits/2026/01/glp-1-coverage-obesity-and-the-ada-what-employer-health-plan-sponsors-need-to-know


node_name: GLP-1 Agricultural Commodity Price Deflation
created_at: 2026-04-19 13:39:02
url:
https://farmdocdaily.illinois.edu/2025/03/consumers-expectations-about-glp-1-drugs-economic-impact-on-food-system-players.html

title:
farmdocdaily.illinois.edu: Consumers expectations about glp 1 drugs economic impact on food system players


title: Science: Popular obesity drug fails hotly anticipated alzheimer s trials
node_name: GLP-1 EVOKE Alzheimer Trial Failure
created_at: 2026-04-19 13:39:02
url:
https://www.science.org/content/article/popular-obesity-drug-fails-hotly-anticipated-alzheimer-s-trials


title: neurologylive.com: Glp 1 semaglutide fails outperform placebo phase 3 evoke trial ad
node_name: GLP-1 EVOKE Alzheimer Trial Failure
created_at: 2026-04-19 13:39:02
url:
https://www.neurologylive.com/view/glp-1-semaglutide-fails-outperform-placebo-phase-3-evoke-trial-ad


node_name: GLP-1 EVOKE Alzheimer Trial Failure
created_at: 2026-04-19 13:39:02
url:
https://www.alzdiscovery.org/news-room/announcements/readout-of-phase-3-semaglutide-trials-marks-critical-moment-in-alzheimers-research

title:
alzdiscovery.org: Readout of phase 3 semaglutide trials marks critical moment in alzheimers research


title: morganlewis.com: Glp 1 coverage obesity and the ada what employer health plan sponsors need to know
node_name: GLP-1 Self-Insured Employer Concentration Risk
created_at: 2026-04-19 13:39:02
url:
https://www.morganlewis.com/blogs/mlbenefits/2026/01/glp-1-coverage-obesity-and-the-ada-what-employer-health-plan-sponsors-need-to-know


title: resourcecenter.omadahealth.com: Glp 1 demand spotlights existing inequities in obesity care
node_name: GLP-1 Racial Equity Access Paradox
created_at: 2026-04-19 13:39:02
url:
https://resourcecenter.omadahealth.com/proof-points/glp-1-demand-spotlights-existing-inequities-in-obesity-care


title: icer.org: ICER Obesity Policy Recommendations For Publication 121625
node_name: GLP-1 Racial Equity Access Paradox
created_at: 2026-04-19 13:39:02
url:
https://icer.org/wp-content/uploads/2025/12/ICER_Obesity_Policy-Recommendations_For-Publication_121625.pdf


title: uhhospitals.org: How glp 1 drugs can affect fertility and birth control
node_name: GLP-1 PCOS Fertility Revolution
created_at: 2026-04-19 13:39:02
url:
https://www.uhhospitals.org/blog/articles/2025/12/how-glp-1-drugs-can-affect-fertility-and-birth-control


node_name: GLP-1 Psychiatric Safety Cleared with Eating Disorder Caveat
created_at: 2026-04-19 13:39:02
url:
https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp

title:
fda.gov: Fda requests removal suicidal behavior and ideation warning glucagon peptide 1 receptor agonist glp


title: pwc.com: Glp 1 trends and impact on business models
node_name: Ultra-Processed Food Dopamine Capture Business Model
created_at: 2026-04-19 13:39:02
url:
https://www.pwc.com/us/en/services/consulting/business-model-reinvention/glp-1-trends-and-impact-on-business-models.html


node_name: GLP-1 Life Insurance Adverse Selection Time Bomb
created_at: 2026-04-19 13:39:02
url:
https://blog.newhorizonsmktg.com/glp-1-weight-loss-drugs-are-creating-life-insurance-problems-for-your-clients

title:
blog.newhorizonsmktg.com: Glp 1 weight loss drugs are creating life insurance problems for your clients


title: swissre.com: 3f8ec083 2b76 4eea 88cb e5af644e045d
node_name: GLP-1 Longevity Annuity Liability Flip
created_at: 2026-04-19 13:39:02
url:
https://www.swissre.com/press-release/GLP-1-drugs-may-reduce-mortality-by-up-to-6-4-in-the-US-by-2045/3f8ec083-2b76-4eea-88cb-e5af644e045d


title: insurancenewsnet.com: Swiss re study glp 1 drugs could cut u s mortality by staggering 6 4 by 2045
node_name: GLP-1 Longevity Annuity Liability Flip
created_at: 2026-04-19 13:39:02
url:
https://insurancenewsnet.com/innarticle/swiss-re-study-glp-1-drugs-could-cut-u-s-mortality-by-staggering-6-4-by-2045


title: realagriculture.com: How glp 1s will shift consumer food habits and why it matters for agriculture
node_name: GLP-1 Global Agricultural Demand Bifurcation
created_at: 2026-04-19 13:39:02
url:
https://www.realagriculture.com/2026/01/how-glp-1s-will-shift-consumer-food-habits-and-why-it-matters-for-agriculture/


node_name: GLP-1 Surgical Volume Disruption
created_at: 2026-04-19 13:39:02
url:
https://openminds.com/market-intelligence/news/bariatric-surgery-volumes-declined-46-over-three-years-as-glp-1-prescription-rates-increased/

title:
openminds.com: Bariatric surgery volumes declined 46 over three years as glp 1 prescription rates increased


title: endocrine.org: Glp1s show promise in treating alcohol and drug addiction
node_name: GLP-1 Addiction Economy Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.endocrine.org/news-and-advocacy/news-room/2025/glp1s-show-promise-in-treating-alcohol-and-drug-addiction


title: beveragedaily.com: Five ways glp 1 drugs are affecting the beverage industry
node_name: GLP-1 Addiction Economy Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.beveragedaily.com/Article/2025/12/19/five-ways-glp-1-drugs-are-affecting-the-beverage-industry/


title: clarivate.com: Drugs to watch 2026 qa lillys next generation weight loss drugs
node_name: GLP-1 Next-Generation Arms Race
created_at: 2026-04-19 13:39:02
url:
https://clarivate.com/life-sciences-healthcare/blog/drugs-to-watch-2026-qa-lillys-next-generation-weight-loss-drugs/


title: retaweightloss.com: Complete retatrutide guide 2026 phase 3 trials timeline whats next
node_name: GLP-1 Next-Generation Arms Race
created_at: 2026-04-19 13:39:02
url:
https://www.retaweightloss.com/article/complete-retatrutide-guide-2026-phase-3-trials-timeline-whats-next


node_name: GLP-1 Price Cliff Mechanism
created_at: 2026-04-19 13:39:02
url:
https://www.drugdiscoverytrends.com/novo-slashes-us-glp-1-prices-by-up-to-70-but-2026-semaglutide-revenue-could-hold-steady-or-even-grow/

title:
drugdiscoverytrends.com: Novo slashes us glp 1 prices by up to 70 but 2026 semaglutide revenue could hold steady or even grow


title: altitudesmagazine.com: Glp 1 drugs approved for cardiovascular protection now reach 34 million
node_name: GLP-1 Price Cliff Mechanism
created_at: 2026-04-19 13:39:02
url:
https://www.altitudesmagazine.com/glp-1-drugs-approved-for-cardiovascular-protection-now-reach-34-million/


title: beckershospitalreview.com: Bariatric surgery volumes continue falling amid glp 1 boom
node_name: GLP-1 Bariatric Surgery Market Displacement
created_at: 2026-04-19 13:39:02
url:
https://www.beckershospitalreview.com/glp-1s/bariatric-surgery-volumes-continue-falling-amid-glp-1-boom/


title: medcitynews.com: Eli lilly oral glp 1 fda approval foundayo orforglipron obesity weight loss lly
node_name: Oral GLP-1 Small Molecule Access Revolution
created_at: 2026-04-19 13:39:02
url:
https://medcitynews.com/2026/04/eli-lilly-oral-glp-1-fda-approval-foundayo-orforglipron-obesity-weight-loss-lly/


node_name: GLP-1 Sarcopenia-Metabolic Rate Trap
created_at: 2026-04-19 13:39:02
url:
https://harvardsciencereview.org/2026/02/23/the-glp-1-aftermath-what-the-science-says-about-muscle-loss-and-cellular-aging/

title:
harvardsciencereview.org: The glp 1 aftermath what the science says about muscle loss and cellular aging


title: who.int: 01 12 2025 who issues global guideline on the use of glp 1 medicines in treating obesity
node_name: GLP-1 Global Access Equity Fault Line
created_at: 2026-04-19 13:39:02
url:
https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity


title: india-briefing.com: Ozempic generic glp1 drug manufacturing race in india 43676
node_name: GLP-1 Global Access Equity Fault Line
created_at: 2026-04-19 13:39:02
url:
https://www.india-briefing.com/news/ozempic-generic-glp1-drug-manufacturing-race-in-india-43676.html/


title: idf.org: Who adds glp 1 therapies and rapid rapid acting insulins to essential medicines list
node_name: GLP-1 Global Access Equity Fault Line
created_at: 2026-04-19 13:39:02
url:
https://idf.org/news/who-adds-glp-1-therapies-and-rapid-rapid-acting-insulins-to-essential-medicines-list/


title: cnbc.com: Novo nordisk ends legal proceedings hims hers compounded weight loss drugs
node_name: GLP-1 Compounding Gray Market Collapse
created_at: 2026-04-19 13:39:02
url:
https://www.cnbc.com/2026/03/09/novo-nordisk-ends-legal-proceedings-hims-hers-compounded-weight-loss-drugs.html


node_name: GLP-1 Compounding Gray Market Collapse
created_at: 2026-04-19 13:39:02
url:
https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next-

title:
pharmacytimes.com: Fda and novo nordisk warned of glp 1 telehealth compounding take down what s next


title: cer.econ.columbia.edu: Novo nordisk economy denmarks growing dependence single pharma giant
node_name: Denmark Novo Nordisk Nokia Concentration Risk
created_at: 2026-04-19 13:39:02
url:
https://cer.econ.columbia.edu/news/novo-nordisk-economy-denmarks-growing-dependence-single-pharma-giant


title: cnbc.com: Denmark slashes 2025 growth forecast amid novo nordisk slowdown
node_name: Denmark Novo Nordisk Nokia Concentration Risk
created_at: 2026-04-19 13:39:02
url:
https://www.cnbc.com/2025/08/29/denmark-slashes-2025-growth-forecast-amid-novo-nordisk-slowdown-.html


title: standrewseconomist.com: When one company rules the fragility of denmarks novo led economy
node_name: Denmark Novo Nordisk Nokia Concentration Risk
created_at: 2026-04-19 13:39:02
url:
https://standrewseconomist.com/2025/02/14/when-one-company-rules-the-fragility-of-denmarks-novo-led-economy/


title: fortune.com: Novo nordisk market value 570 billion bigger than danish denmark economy
node_name: Novo Nordisk Denmark Single-Company Systemic Risk
created_at: 2026-04-19 13:39:02
url:
https://fortune.com/europe/2024/05/01/novo-nordisk-market-value-570-billion-bigger-than-danish-denmark-economy/


title: euronews.com: The ozempic effect from shopping baskets to dips in danish gdp
node_name: Novo Nordisk Denmark Single-Company Systemic Risk
created_at: 2026-04-19 13:39:02
url:
https://www.euronews.com/business/2025/09/02/the-ozempic-effect-from-shopping-baskets-to-dips-in-danish-gdp


title: cnbc.com: Td cowen downgrades novo nordisk on concerns over semaglutide patent loss
node_name: Novo Nordisk Denmark Single-Company Systemic Risk
created_at: 2026-04-19 13:39:02
url:
https://www.cnbc.com/2026/03/10/td-cowen-downgrades-novo-nordisk-on-concerns-over-semaglutide-patent-loss.html


title: fiercehealthcare.com: Fda declares semaglutide shortage over spelling end compounded glp 1 market
node_name: Compounding Pharmacy GLP-1 Shadow Market Collapse
created_at: 2026-04-19 13:39:02
url:
https://www.fiercehealthcare.com/health-tech/fda-declares-semaglutide-shortage-over-spelling-end-compounded-glp-1-market


node_name: Compounding Pharmacy GLP-1 Shadow Market Collapse
created_at: 2026-04-19 13:39:02
url:
https://www.sheppardhealthlaw.com/2025/03/articles/fda/fdas-semaglutide-shortage-resolution-legal-implications-and-risks-for-compounding-pharmacies/

title:
sheppardhealthlaw.com: Fdas semaglutide shortage resolution legal implications and risks for compounding pharmacies


title: thedrinksbusiness.com: Glp 1 drugs reshape alcohol consumption and hospitality habits
node_name: GLP-1 Alcohol Industry Demand Destruction Mechanism
created_at: 2026-04-19 13:39:02
url:
https://www.thedrinksbusiness.com/2026/04/glp-1-drugs-reshape-alcohol-consumption-and-hospitality-habits/


title: daily.sevenfifty.com: Ozempic curbs drinking so what does that mean for the alcohol industry
node_name: GLP-1 Alcohol Industry Demand Destruction Mechanism
created_at: 2026-04-19 13:39:02
url:
https://daily.sevenfifty.com/ozempic-curbs-drinking-so-what-does-that-mean-for-the-alcohol-industry/


title: medcentral.com: Semaglutide fails to meet desired endpoints for alzheimers
node_name: GLP-1 EVOKE Alzheimer's Trial Failure and What It Reveals
created_at: 2026-04-19 13:39:02
url:
https://www.medcentral.com/neurology/dementia/semaglutide-fails-to-meet-desired-endpoints-for-alzheimers


title: pharmaceutical-technology.com: Novo nordisk shares tumble 18 after 2026 sales dip warning
node_name: Novo Nordisk Competitive Collapse Sequence
created_at: 2026-04-19 13:39:02
url:
https://www.pharmaceutical-technology.com/news/novo-nordisk-shares-tumble-18-after-2026-sales-dip-warning/


title: insights.woozleresearch.com: Novo nordisk cagrisema price cuts and the end of pipeline superiority
node_name: Novo Nordisk Competitive Collapse Sequence
created_at: 2026-04-19 13:39:02
url:
https://insights.woozleresearch.com/novo-nordisk-cagrisema-price-cuts-and-the-end-of-pipeline-superiority/


title: fiercebiotech.com: Novo nordisk stock crashes after cagrisema misses phase 3 weight loss goal
node_name: Novo Nordisk Competitive Collapse Sequence
created_at: 2026-04-19 13:39:02
url:
https://www.fiercebiotech.com/biotech/novo-nordisk-stock-crashes-after-cagrisema-misses-phase-3-weight-loss-goal


title: massgeneralbrigham.org: Study finds bariatric surgery declined with rise in glp 1 drugs
node_name: GLP-1 Hospital Revenue Destruction
created_at: 2026-04-19 13:39:02
url:
https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs


title: fiercepharma.com: Medicare unveils price reductions 15 drugs including novos semaglutide
node_name: GLP-1 IRA Medicare Federal Budget Reckoning
created_at: 2026-04-19 13:39:02
url:
https://www.fiercepharma.com/pharma/medicare-unveils-price-reductions-15-drugs-including-novos-semaglutide


title: longevitytoday.com: Glp 1 drugs fight inflammation beyond weight loss in obesity and diabetes
node_name: GLP-1 Direct Anti-Inflammatory Cardiovascular Mechanism
created_at: 2026-04-19 13:39:02
url:
https://longevitytoday.com/articles/glp-1-drugs-fight-inflammation-beyond-weight-loss-in-obesity-and-diabetes


title: phti.org: PHTI Employer Approaches to GLP 1 Coverage Market Trend Report
node_name: GLP-1 Employer ROI vs Insurer Prisoner's Dilemma
created_at: 2026-04-19 13:39:02
url:
https://phti.org/wp-content/uploads/sites/3/2025/12/PHTI-Employer-Approaches-to-GLP-1-Coverage-Market-Trend-Report.pdf


node_name: GLP-1 Employer ROI vs Insurer Prisoner's Dilemma
created_at: 2026-04-19 13:39:02
url:
https://www.ebri.org/content/glp-1-coverage-and-its-impact-on-employment-based-health-plan-premiums--a-simulation-based-analysis

title:
ebri.org: Glp 1 coverage and its impact on employment based health plan premiums a simulation based analysis


title: Science: Obesity drugs linked lower addiction rates large study veterans
node_name: GLP-1 Addiction-Craving Suppression Multi-Disorder Economy
created_at: 2026-04-19 13:39:02
url:
https://www.science.org/content/article/obesity-drugs-linked-lower-addiction-rates-large-study-veterans


node_name: GLP-1 Compounding Pharmacy Shutdown Access Cliff
created_at: 2026-04-19 13:39:02
url:
https://markets.financialcontent.com/stocks/article/marketminute-2026-3-4-the-compounding-cliff-hims-and-hers-faces-reckoning-as-fda-and-big-pharma-close-glp-1-loopholes

title:
markets.financialcontent.com: Marketminute 2026 3 4 the compounding cliff hims and hers faces reckoning as fda and big pharma close glp 1 loopholes


title: harrisbeachmurtha.com: Glp 1 weight loss drugs off shortage list deadlines to stop compounding
node_name: GLP-1 Compounding Pharmacy Shutdown Access Cliff
created_at: 2026-04-19 13:39:02
url:
https://www.harrisbeachmurtha.com/insights/glp-1-weight-loss-drugs-off-shortage-list-deadlines-to-stop-compounding/


node_name: GLP-1 Manufacturing Duopoly Geopolitical Concentration
created_at: 2026-04-19 13:39:02
url:
https://www.fiercepharma.com/pharma/2025-forecast-after-novo-lilly-expansion-sprees-positive-signals-emerge-around-future-supply

title:
fiercepharma.com: 2025 forecast after novo lilly expansion sprees positive signals emerge around future supply


title: inkl.com: Novo nordisk s stock slump shows the glp 1 trade s side effect etf concentration risk
node_name: GLP-1 Manufacturing Duopoly Geopolitical Concentration
created_at: 2026-04-19 13:39:02
url:
https://www.inkl.com/news/novo-nordisk-s-stock-slump-shows-the-glp-1-trade-s-side-effect-etf-concentration-risk


title: shrm.org: Employers project big jump health care costs 2026
node_name: GLP-1 Workforce Disability Morbidity Compression
created_at: 2026-04-19 13:39:02
url:
https://www.shrm.org/topics-tools/news/benefits-compensation/employers-project-big-jump-health-care-costs-2026


title: theiwsr.com: Global beverage alcohol to drop further due to declines in us and china
node_name: GLP-1 Alcohol Industry Structural Disruption
created_at: 2026-04-19 13:39:02
url:
https://www.theiwsr.com/insight/press-release/global-beverage-alcohol-to-drop-further-due-to-declines-in-us-and-china/


node_name: GLP-1 AI Drug Discovery Feedback Loop
created_at: 2026-04-19 13:39:02
url:
https://nvidianews.nvidia.com/news/nvidia-and-lilly-announce-co-innovation-lab-to-reinvent-drug-discovery-in-the-age-of-ai

title:
nvidianews.nvidia.com: Nvidia and lilly announce co innovation lab to reinvent drug discovery in the age of ai


node_name: GLP-1 AI Drug Discovery Feedback Loop
created_at: 2026-04-19 13:39:02
url:
https://www.proactiveinvestors.com/companies/news/1090487/glp-1-giant-novo-nordisk-partners-with-openai-as-pharma-industry-s-ai-race-accelerates-1090487.html

title:
proactiveinvestors.com: Glp 1 giant novo nordisk partners with openai as pharma industry s ai race accelerates 1090487


title: facs.org: Bariatric surgeons consider sustainability of bariatric surgery in glp 1 era
node_name: GLP-1 PE Healthcare Rollup Destruction and Rebirth
created_at: 2026-04-19 13:39:02
url:
https://www.facs.org/for-medical-professionals/conferences-and-meetings/clinical-congress-2025/cc2025-news/bariatric-surgeons-consider-sustainability-of-bariatric-surgery-in-glp-1-era/


title: ir.ipatherapeutics.com: Default
node_name: GLP-1 AI Peptide Design Arms Race
created_at: 2026-04-19 13:39:02
url:
https://ir.ipatherapeutics.com/news/news-releases/news-details/2025/AI-Designed-GLP-1-Peptides-from-ImmunoPrecise-Antibodies-Surpass-Semaglutide-in-Receptor-Activation-Studies/default.aspx


title: troweprice.com: Could glp 1s help rebalance the food trilemma
node_name: GLP-1 Obesity-Climate Industrial Food System Nexus
created_at: 2026-04-19 13:39:02
url:
https://www.troweprice.com/personal-investing/resources/insights/could-glp-1s-help-rebalance-the-food-trilemma.html


title: benefitsandpensionsmonitor.com: 392290
node_name: GLP-1 Annuity Pension Longevity Solvency Trap
created_at: 2026-04-19 13:39:02
url:
https://www.benefitsandpensionsmonitor.com/pensions/retirement-planning/glp-1s-can-lead-to-better-retirement-outcomes-actuary/392290


node_name: GLP-1 China Manufacturing Geopolitical Chokepoint
created_at: 2026-04-19 13:39:02
url:
https://www.pharmaceuticalcommerce.com/view/lilly-bolsters-glp1-supply-chain-pledging-3-billion-manufacturing-expansion-in-china

title:
pharmaceuticalcommerce.com: Lilly bolsters glp1 supply chain pledging 3 billion manufacturing expansion in china


node_name: GLP-1 China Manufacturing Geopolitical Chokepoint
created_at: 2026-04-19 13:39:02
url:
https://democrats-selectcommitteeontheccp.house.gov/media/press-releases/krishnamoorthi-sends-letters-to-chinese-biotech-firms-regarding-illicit-and

title:
democrats-selectcommitteeontheccp.house.gov: Krishnamoorthi sends letters to chinese biotech firms regarding illicit and


node_name: GLP-1 China Manufacturing Geopolitical Chokepoint
created_at: 2026-04-19 13:39:02
url:
https://www.indianpharmapost.com/news/pharma-firms-accelerate-regional-glp-1-capacity-to-de-risk-supply-chains-amid-geopolitical-tensions-globaldata-19728

title:
indianpharmapost.com: Pharma firms accelerate regional glp 1 capacity to de risk supply chains amid geopolitical tensions globaldata 19728


node_name: GLP-1 Dialysis Paradox
created_at: 2026-04-19 13:39:02
url:
https://markets.financialcontent.com/stocks/article/finterra-2026-2-11-the-dialysis-renaissance-how-davita-dva-conquered-the-glp-1-fear-and-defined-healthcare-resilience-in-2026

title:
markets.financialcontent.com: Finterra 2026 2 11 the dialysis renaissance how davita dva conquered the glp 1 fear and defined healthcare resilience in 2026


node_name: Orforglipron Oral Access Democratization
created_at: 2026-04-19 13:39:02
url:
https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html

title:
prnewswire.com: Fda approves lillys foundayo orforglipron the only glp 1 pill for weight loss that can be taken any time of day without food or water restrictions 302731485


title: investor.lilly.com: Lillys oral glp 1 orforglipron demonstrated statistically
node_name: Orforglipron Oral Access Democratization
created_at: 2026-04-19 13:39:02
url:
https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-demonstrated-statistically


node_name: Retatrutide Triple Agonist Succession Wave
created_at: 2026-04-19 13:39:02
url:
https://www.fiercebiotech.com/biotech/eli-lillys-obesity-triple-threat-smashes-efficacy-expectations-phase-3-proves-intolerable

title:
fiercebiotech.com: Eli lillys obesity triple threat smashes efficacy expectations phase 3 proves intolerable


title: statnews.com: Novo nordisk semaglutide wegovy ozempic alzheimers trial failure
node_name: GLP-1 EVOKE Alzheimer's Trial Catastrophic Failure
created_at: 2026-04-19 13:39:02
url:
https://www.statnews.com/2025/11/24/novo-nordisk-semaglutide-wegovy-ozempic-alzheimers-trial-failure/


node_name: GLP-1 EVOKE Alzheimer's Trial Catastrophic Failure
created_at: 2026-04-19 13:39:02
url:
https://www.neurologylive.com/view/ctad-presentation-lays-insights-disappointing-phase-3-evoke-trial-of-glp-1-semaglutide-alzheimers

title:
neurologylive.com: Ctad presentation lays insights disappointing phase 3 evoke trial of glp 1 semaglutide alzheimers


title: clinicaltrialsarena.com: Ad pd 2026 novo nordisk semaglutide early alzheimers
node_name: GLP-1 EVOKE Alzheimer's Trial Catastrophic Failure
created_at: 2026-04-19 13:39:02
url:
https://www.clinicaltrialsarena.com/analyst-comment/ad-pd-2026-novo-nordisk-semaglutide-early-alzheimers/


title: newsroom.regeneron.com: Interim results ongoing phase 2 courage trial confirm potential
node_name: GLP-1 Sarcopenia Paradox: The Hidden Cost of Weight Loss
created_at: 2026-04-19 13:39:02
url:
https://newsroom.regeneron.com/news-releases/news-release-details/interim-results-ongoing-phase-2-courage-trial-confirm-potential


node_name: GLP-1 Cancer Prevention Cascade
created_at: 2026-04-19 13:39:02
url:
https://www.endocrinologyadvisor.com/news/glp-1-receptor-agonist-use-linked-to-reduced-overall-risk-for-cancer-in-adults-with-obesity/

title:
endocrinologyadvisor.com: Glp 1 receptor agonist use linked to reduced overall risk for cancer in adults with obesity


node_name: GLP-1 Cancer Prevention Cascade
created_at: 2026-04-19 13:39:02
url:
https://www.oncology-central.com/asco-2025-glp-1-agonists-show-potential-in-reducing-obesity-related-cancer-risk/

title:
oncology-central.com: Asco 2025 glp 1 agonists show potential in reducing obesity related cancer risk


node_name: GLP-1 Life Insurance Actuarial Mispricing Crisis
created_at: 2026-04-19 13:39:02
url:
https://wealthstrategiesjournal.com/2025/07/22/glp-1-digest-how-weight-loss-medications-are-creating-a-crisis-in-life-insurance-risk-assessment-jun-22-2025/

title:
wealthstrategiesjournal.com: Glp 1 digest how weight loss medications are creating a crisis in life insurance risk assessment jun 22 2025


title: swissre.com: Future of metabolic health and weight loss drugs
node_name: GLP-1 Life Insurance Actuarial Mispricing Crisis
created_at: 2026-04-19 13:39:02
url:
https://www.swissre.com/risk-knowledge/living-longer-healthier-lives/future-of-metabolic-health-and-weight-loss-drugs.html


title: imperial.ac.uk: Weight loss drugs and alzheimers disease is there hope for future
node_name: GLP-1 Alzheimer's Neuroprotection Split Signal
created_at: 2026-04-19 13:39:02
url:
https://www.imperial.ac.uk/news/articles/medicine/brain-sciences/2026/weight-loss-drugs-and-alzheimers-disease--is-there-hope-for-future-/


title: neurologylive.com: Repositioning glp 1 drugs neurologic disease evidence advances outlook
node_name: GLP-1 Alzheimer's Neuroprotection Split Signal
created_at: 2026-04-19 13:39:02
url:
https://www.neurologylive.com/view/repositioning-glp-1-drugs-neurologic-disease-evidence-advances-outlook


node_name: Orforglipron Small Molecule Manufacturing Revolution
created_at: 2026-04-19 13:39:02
url:
https://www.pharmacytimes.com/view/fda-approves-orforglipron-first-glp-1-pill-without-time-food-or-water-restrictions

title:
pharmacytimes.com: Fda approves orforglipron first glp 1 pill without time food or water restrictions


title: cnbc.com: Novo nordisk cheap weight loss drugs india generic ozempic wegovy semaglutide
node_name: Semaglutide Biosimilar Global Access Cascade
created_at: 2026-04-19 13:39:02
url:
https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html


title: iqvia.com: Your questions answered off patent semaglutide in 2026
node_name: Semaglutide Biosimilar Global Access Cascade
created_at: 2026-04-19 13:39:02
url:
https://www.iqvia.com/locations/emea/blogs/2026/04/your-questions-answered-off-patent-semaglutide-in-2026


title: uab.edu: New uab discovery may solve glp 1s biggest problem weight regain after stopping treatment
node_name: GLP-1 Chronic Dependency Trap
created_at: 2026-04-19 13:39:02
url:
https://www.uab.edu/news/research-innovation/new-uab-discovery-may-solve-glp-1s-biggest-problem-weight-regain-after-stopping-treatment


title: ajmc.com: Weight regain after glp 1 discontinuation is less rapid in real world hamlet gasoyan phd
node_name: GLP-1 Chronic Dependency Trap
created_at: 2026-04-19 13:39:02
url:
https://www.ajmc.com/view/weight-regain-after-glp-1-discontinuation-is-less-rapid-in-real-world-hamlet-gasoyan-phd


